For Immediate Release
Contact: mktgcomm@tams.com

TOSHIBA INSTALLS THE AQUILION 64 CFX AT CARDIOVASCULAR INSTITUTE OF THE SOUTH

64-Slice Detector CT Delivers True Volumetric Imaging For Faster, More Accurate Diagnosis of Cardiovascular Disease

ACC Booth #3551 Hall D

TUSTIN, Calif., March 1, 2005 – Expanding the clinical application of multislice computed tomography (CT) in cardiology, Toshiba America Medical Systems, Inc. (TAMS) today announced the installation of two Aquilion^TM 64 CFX multislice CT systems at the Cardiovascular Institute of the South (CIS) in Louisiana. CIS is one of the largest, most comprehensive and advanced centers for nonsurgical and surgical treatment of heart and vascular disease in the United States.

Toshiba will demonstrate the Aquilion 64 CFX and its advanced cardiac applications at the 2005 Annual Scientific Session of the American College of Cardiology (ACC) in Orlando, Fla.

"By offering the most comprehensive set of cardiovascular CT imaging capabilities with the Aquilion 64 CFX, Toshiba is raising the standard of care in cardiology with faster, more accurate and complete cardiac exams," said Doug Ryan, director, CT Business Unit, Toshiba America Medical Systems, Inc. "With our multiple systems at CIS, cardiologists can take advantage of Toshiba’s superior 64-row Quantum detector and volumetric imaging technology that enable complete coverage of the heart within a five to ten second breath-hold."

Founded in the small southern Louisiana city of Houma, an area with one of the highest incidences of cardiovascular disease in the industrialized world, CIS is a group of more than 30 cardiologists and cardiovascular surgeons representing every specialty in heart and circulatory medicine.

"Our interventional practice has already experienced tremendous benefits with Toshiba’s previous Aquilion multislice CT technology for peripheral vascular imaging. The installation of two new Aquilion 64 CFX scanners will provide CIS with additional coronary artery imaging capabilities, while dramatically increasing examination quality with even faster CT scans and improved overall image quality," said Joey Fontenot, chief operating officer, Cardiovascular Institute of the South. "CIS will soon be able to take advantage of the most advanced 64-slice CT technology available to perform comprehensive coronary and peripheral vascular imaging studies to aid in the diagnosis and planning of interventional procedures."

Most Advanced 64-Slice CT System

Built on the same platform as the Aquilion 32 CFX, the Aquilion 64 CFX features the industry’s most advanced multi-detector CT imaging technology available. Utilizing Toshiba’s unique 64-row Quantum detector, the Aquilion 64 CFX is designed to deliver high-speed, high-resolution cardiovascular imaging with the lowest noise and most anatomical coverage.

The Quantum detector also enables the Aquilion scanner to acquire 64 simultaneous slices of 0.5 mm with each 400-millisecond gantry revolution. The result is the most precise isotropic imaging of the heart or any region of the body during a breath-hold under 10 seconds.

For more information about the Aquilion 64 CFX with the Quantum detector, TAMS and its wide range of medical imaging products, please visit www.medical.toshiba.com.

About Toshiba

With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corporation, an independent group company of Toshiba Corporation, is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corporation is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $53 billion.

Aquilion^TM is a trademark of Toshiba Medical Systems Corporation.